Hu Q, Zhou X, Sun Y. RE: Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208). J Natl Cancer Inst 2024 Oct 16:djae257. doi: 10.1093.
PMID: 39412862